Contribution
My Lords, I wholeheartedly congratulate my noble friend on such a thoughtful and important contribution and on securing the debate in the first place.
In the Government’s 10-year health plan, published last year, a member of the public described the difficulties of caring for a mother with dementia. Despite being directed towards numerous services, there was, in her words, no one taking responsibility for a solution. It is deeply troubling. A diagnosis should mark the beginning of a pathway to a dependable relationship with services, not the point at which families are left to navigate an increasingly complicated and confusing system on their own.
I congratulate Alzheimer’s Research UK, which reminds us that nearly 1 million people in the UK are living with dementia. One in three do not have a formal diagnosis. One only has to reflect on the anxiety and stress this causes to the individual and the families concerned. People can come to terms with almost anything; the real killer is uncertainty.
The geographical differences are striking. In Richmond, south-west London, the average waiting time for a diagnosis is 69 days. In Richmond, North Yorkshire—we must tell Rishi Sunak—it is 248 days. What can justify such a disparity? NICE guidance is admirably clear: every person living with dementia should have a named professional responsible for co-ordinating their care. The latest NHS England figures published in October show that only 63% of patients with a dementia diagnosis had a care plan or review recorded in the preceding 12 months. Can the Minister explain what practical steps the Government are taking to ensure that every patient has a named professional responsible for co-ordinating their continuing care?
I also commend the remarkable and dedicated contribution from my noble friend Lord Cameron of Chipping Norton. As Prime Minister, he launched the Dementia Challenge in 2012, helping to transform the national conversation about a condition too often regarded as an inevitable consequence of aging. He doubled the investment in dementia research and brought international leaders together at the G8 Dementia Summit in 2013. His efforts have not diminished since leaving office. As my noble friend said, he is beginning a podcast and has been talking movingly about his mother, whom I remember fondly. He has spoken about the possibility of a statin for the brain, a treatment that might one day prevent or delay Alzheimer’s disease, just as statins have transformed cardiovascular prevention.
There are many hopeful signs grounded in genuine advances in science. The first medicines shown to slow Alzheimer’s progression have been licensed in the UK, but they are not routinely available through the NHS. As a former Health Secretary, I fully recognise the importance of rigorous assessment of safety and cost-effectiveness, but I also recognise the signs of taking time and delaying before the Government have to take on the cost of some of these new advances that are wonderful but have serious resource implications.
Alzheimer’s Research UK has articulated a compelling vision: a world free from the fear, harm and heartbreak of dementia. In its 10-year strategy, Towards a Cure, it envisages earlier and more accurate diagnosis, access to effective treatments and, ultimately preventing more people from developing these diseases. The charity’s recent Ready for a Cure report makes an equally important argument: scientific breakthroughs cannot improve patients’ lives unless the NHS has the capacity to adopt them, support clinical trials and provide appropriate care.
Vascular dementia deserves particular consideration. Managing blood pressure, diabetes and other cardiovascular risks can help reduce further damage, while rehabilitation and OT can preserve independence. But such care depends on continuity between primary care, specialist services and support at home. I am sure that noble Lords are aware of research from King’s College London finding that inadequate community provision could make hospital emergency departments the path of least resistance to accessing care. We all know that, once a patient has been admitted through an emergency department, it is much more difficult to return them home.
Let me mention unpaid carers. For many years, I worked with the late Baroness Seear. I was vice-chairman of what became Carers UK. The bravest thing we ever did was appoint a new chief executive. This was an unknown woman from Reading by the name of Jill Pitkeathley. Of course, she has gone from strength to strength but, at the time, it was quite a risky appointment; we spent a great deal of time deciding whether it was the right one to make. There is nothing more exciting than making an appointment that transforms the situation. But carers were simply not known about. I remember going on a programme to talk about it and they said, “This is Mrs Bottomley from the careers service”. This was not a term that was widely used.
Another example of great courage and perseverance is Alastair Stewart, the broadcaster, and his courageous wife Sally, who are dear friends of mine. They have been involved in the Daily Mail’s Dementia Carers Together appeal, in partnership with the Alzheimer’s Society and Alzheimer’s Scotland. Talking in public about these conditions is always painful and intrusive, but so often it is the human story that makes people think. Rather wonderfully, Alastair said, “What happens to the people who don’t have a Sal?”—a good point indeed.
I also express my admiration for the Alzheimer’s Society, Dementia UK, Age UK and the many local charities whose dedication, specialist knowledge and personal relationships make such a difference. There are now genuine reasons for optimism. We are entering a new era in dementia research. For the first time, we have treatments that have been licensed and have been shown to halt or slow the progression of the disease. Blood-based biomarkers offer the potential to transform diagnosis, and make it faster and more accessible. Advances in research, diagnostics and healthcare data are opening up possibilities that would have been absolutely unimaginable a few years past. What we need is action, coherence and a timetable. I commend my noble friend Lord Jackson once more and look forward to the Minister’s comments.